BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 36091792)

  • 1. Dietary stilbenes as modulators of specific miRNAs in prostate cancer.
    Levenson AS
    Front Pharmacol; 2022; 13():970280. PubMed ID: 36091792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis-associated protein 1-mediated antitumor and anticancer activity of dietary stilbenes for prostate cancer chemoprevention and therapy.
    Levenson AS
    Semin Cancer Biol; 2022 May; 80():107-117. PubMed ID: 32126261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer.
    Kumar A; Rimando AM; Levenson AS
    Ann N Y Acad Sci; 2017 Sep; 1403(1):15-26. PubMed ID: 28662290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary Pterostilbene for MTA1-Targeted Interception in High-Risk Premalignant Prostate Cancer.
    Hemani R; Patel I; Inamdar N; Campanelli G; Donovan V; Kumar A; Levenson AS
    Cancer Prev Res (Phila); 2022 Feb; 15(2):87-100. PubMed ID: 34675064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer.
    Dhar S; Kumar A; Zhang L; Rimando AM; Lage JM; Lewin JR; Atfi A; Zhang X; Levenson AS
    Oncotarget; 2016 Apr; 7(14):18469-84. PubMed ID: 26943043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer.
    Dhar S; Kumar A; Rimando AM; Zhang X; Levenson AS
    Oncotarget; 2015 Sep; 6(29):27214-26. PubMed ID: 26318586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer.
    Kumar A; Dhar S; Rimando AM; Lage JM; Lewin JR; Zhang X; Levenson AS
    Ann N Y Acad Sci; 2015 Aug; 1348(1):1-9. PubMed ID: 26214308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Anticancer Properties of Table Grape Powder Extract (GPE) in Prostate Cancer.
    Kumar A; D'silva M; Dholakia K; Levenson AS
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30463302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting MTA1/HIF-1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression.
    Butt NA; Kumar A; Dhar S; Rimando AM; Akhtar I; Hancock JC; Lage JM; Pound CR; Lewin JR; Gomez CR; Levenson AS
    Cancer Med; 2017 Nov; 6(11):2673-2685. PubMed ID: 29024573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer.
    Li K; Dias SJ; Rimando AM; Dhar S; Mizuno CS; Penman AD; Lewin JR; Levenson AS
    PLoS One; 2013; 8(3):e57542. PubMed ID: 23469203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTA1-Dependent Anticancer Activity of Gnetin C in Prostate Cancer.
    Kumar A; Dholakia K; Sikorska G; Martinez LA; Levenson AS
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31487842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Therapeutic Efficacy and Mechanism of Action of Gnetin C, a Natural Compound from the Melinjo Plant, in a Preclinical Mouse Model of Advanced Prostate Cancer.
    Campanelli G; Francois E; Parupathi P; Devarakonda LS; Yang C; Kumar A; Levenson AS
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex.
    Kai L; Samuel SK; Levenson AS
    Int J Cancer; 2010 Apr; 126(7):1538-48. PubMed ID: 19810103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer.
    Dhar S; Kumar A; Li K; Tzivion G; Levenson AS
    Biochim Biophys Acta; 2015 Feb; 1853(2):265-75. PubMed ID: 25447541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTA family of proteins in prostate cancer: biology, significance, and therapeutic opportunities.
    Levenson AS; Kumar A; Zhang X
    Cancer Metastasis Rev; 2014 Dec; 33(4):929-42. PubMed ID: 25332143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gnetin C Intercepts MTA1-Associated Neoplastic Progression in Prostate Cancer.
    Parupathi P; Campanelli G; Deabel RA; Puaar A; Devarakonda LS; Kumar A; Levenson AS
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.
    Avtanski DB; Nagalingam A; Kuppusamy P; Bonner MY; Arbiser JL; Saxena NK; Sharma D
    Oncotarget; 2015 Jun; 6(18):16396-410. PubMed ID: 26036628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol and prostate cancer: promising role for microRNAs.
    Dhar S; Hicks C; Levenson AS
    Mol Nutr Food Res; 2011 Aug; 55(8):1219-29. PubMed ID: 21714127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Potential of Gnetin C in Prostate Cancer: A Pre-Clinical Study.
    Gadkari K; Kolhatkar U; Hemani R; Campanelli G; Cai Q; Kumar A; Levenson AS
    Nutrients; 2020 Nov; 12(12):. PubMed ID: 33255879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pterostilbene inhibits MTA1/HDAC1 complex leading to PTEN acetylation in hepatocellular carcinoma.
    Qian YY; Liu ZS; Yan HJ; Yuan YF; Levenson AS; Li K
    Biomed Pharmacother; 2018 May; 101():852-859. PubMed ID: 29635894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.